NCT04565795View on ClinicalTrials.gov

Safety and Device Performance of the Uriprene® Degradable Temporary Ureteral Stent Following Uncomplicated Ureteroscopy

NARecruitingINTERVENTIONAL
Enrollment

87

Participants

Timeline

Start Date

July 1, 2022

Primary Completion Date

June 30, 2026

Study Completion Date

September 30, 2026

Conditions
Ureteral Diseases
Interventions
DEVICE

Uriprene® Degradable Temporary Ureteral Stent

Assess adequate intervention-free drainage during use and the time to complete degradation or the passage of stent fragments/segments from the urinary system by radiological assessment.

Trial Locations (4)

32610

RECRUITING

University of Florida, Gainesville

43210

RECRUITING

The Ohio State University, Columbus

85054

RECRUITING

Mayo Clinic Arizona, Phoenix

90404

RECRUITING

University of California Los Angeles, Los Angeles

Sponsors
All Listed Sponsors
collaborator

Northwest Clinical Research Group

UNKNOWN

lead

Adva-Tec

INDUSTRY

NCT04565795 - Safety and Device Performance of the Uriprene® Degradable Temporary Ureteral Stent Following Uncomplicated Ureteroscopy | Biotech Hunter | Biotech Hunter